Skip to content
Clinical Trials – home

Pilocarpine Hydrochloride: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
1+
Countries

In short

Pilocarpine Hydrochloride, a medication with diverse applications, is being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate its effectiveness in addressing issues such as presbyopia, dry eye syndrome, xerostomia, and glaucoma. The research focuses on different formulations and administration methods of pilocarpine, including eye drops, oral tablets, and mouthwashes, to determine its safety and efficacy across various patient populations.

What is Pilocarpine Hydrochloride?

Pilocarpine Hydrochloride is a medication that has been the subject of numerous clinical trials for various medical conditions. It is known by several other names, including AGN-190584, VUITY, and Salagen. This drug belongs to a class of medications called cholinergic agonists, which work by stimulating certain nerve endings in the body.

Uses of Pilocarpine Hydrochloride

Pilocarpine Hydrochloride has been studied for its potential benefits in treating several conditions:

  • Presbyopia: This is an age-related condition where the eye loses its ability to focus on close objects. Several studies have investigated the use of Pilocarpine Hydrochloride eye drops for treating presbyopia.
  • Glaucoma and Ocular Hypertension: These are conditions related to increased pressure in the eye. Pilocarpine has been studied as a potential treatment to lower intraocular pressure.
  • Dry Eye Syndrome: This condition occurs when the eyes don't produce enough tears or the tears evaporate too quickly. Pilocarpine has been investigated for its potential to relieve dry eye symptoms, particularly in patients with Sjögren's syndrome.
  • Dry Mouth (Xerostomia): Pilocarpine has been studied for its ability to stimulate saliva production, which could help patients suffering from dry mouth due to various causes, including cancer treatments.
  • Vaginal Dryness: Research has been conducted on the potential use of Pilocarpine to alleviate vaginal dryness in breast cancer patients.

How Pilocarpine Hydrochloride is Administered

The administration of Pilocarpine Hydrochloride varies depending on the condition being treated:

  • Eye Drops: For conditions like presbyopia and glaucoma, Pilocarpine is often administered as eye drops. The typical concentration used in studies is 1.25%, with one drop applied to each eye once or twice daily.
  • Oral Tablets: For conditions like dry mouth or dry eye associated with Sjögren's syndrome, Pilocarpine may be given as oral tablets. The dosage can range from 5mg to 20mg per day, often divided into multiple doses.
  • Mouthwash: Some studies have investigated the use of Pilocarpine as a mouthwash for treating dry mouth. A concentration of 0.1% has been used in research.

Effectiveness of Pilocarpine Hydrochloride

The effectiveness of Pilocarpine Hydrochloride varies depending on the condition being treated:

  • Presbyopia: Studies have shown promising results in improving near vision in patients with presbyopia. For example, one study found that a significant percentage of participants gained 3 lines or more in near visual acuity after using Pilocarpine eye drops.
  • Dry Eye and Dry Mouth: Research has indicated that Pilocarpine can help stimulate tear and saliva production, potentially alleviating symptoms of dry eye and dry mouth.
  • Glaucoma: Studies have investigated the potential of Pilocarpine to lower intraocular pressure, which is crucial in managing glaucoma.

It's important to note that while these results are promising, the effectiveness can vary from person to person, and more research may be needed to fully understand the drug's efficacy in different conditions.

Potential Side Effects

Like all medications, Pilocarpine Hydrochloride can cause side effects. Some of the reported side effects include:

  • Sweating
  • Nausea
  • Dizziness
  • Headache
  • Changes in vision
  • Increased salivation

The frequency and severity of these side effects can vary depending on the dosage and method of administration. It's crucial to discuss potential side effects with your healthcare provider before starting any new medication.

Ongoing Research and Future Prospects

Pilocarpine Hydrochloride continues to be the subject of ongoing research for various conditions. Current areas of investigation include:

  • Long-term effects of Pilocarpine eye drops for presbyopia.
  • Use of Pilocarpine in preventing dry mouth and mucositis in cancer patients receiving radiation therapy.
  • Potential benefits of Pilocarpine for vaginal dryness in breast cancer patients.

These ongoing studies aim to further our understanding of Pilocarpine's effectiveness, optimal dosing, and potential new applications. As research progresses, we may see expanded uses for this medication in the future.

Questions people often ask

Conditions where Pilocarpine Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Pilocarpine Hydrochloride

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).